Skip Main Navigation
Page Content

Save This Event

Event Saved

The CURE Annual Meeting

CURE

Tuesday, June 13, 2017 from 3:45 PM to 5:00 PM (EDT)

The CURE Annual Meeting

Ticket Information

Type End Quantity
Register   more info Jun 13, 2017 Free  

Share The CURE Annual Meeting

Event Details

Join CURE at The Commons in Groton and hear from leading experts in the bioscience community. Our featured speakers will informally speak to the growth and investment opportunities in Connecticut and the pressing legistative issues facing the US bioscience ecosystem.

The meeting starts at 3:45pm.

CURE Annual Members Meeting Agenda:

WelcomePeter Farina & Stan Choy, Co-Chairs
Call to Order and Annual MeetingFrank Marco, J.D., Secretary
Presentations: 
Susan Froshauer, Ph.D., President & CEO of CURE - "CURE Annual Report"
Mostafa Analoui, Ph.D., Executive Director, UConn Venture Development - "Biotech IPOs: Reading The Tea Leaves"
Patrick Plues, Vice President, State Government Affairs, BIO - "Legislative Matters Arising Concerning the US-wide Bioscience Ecosystem"
Closing Remarks
Picnic at The Commons - Register Here

CURE Annual Report

Susan Froshauer, Ph.D., President, and CEO of CURE. 

Susan is president and CEO of CURE (Connecticut United for Research Excellence, Inc.)(cureconnect.org) and president of CURE Innovation Commons, bioscience incubator with laboratories (curecommons.org).  She has spent over 27 years in biopharmaceuticals research and development. She has experience as a bench scientist, pharmaceutical executive, mentor, entrepreneur and angel investor and special skill at connecting academic expertise and technology with the commercial sector.   Susan is involved with the Yale Entrepreneurial Institute, the CTNEXT-funded UCONN-Yale Program, PITCH and the Thames River Innovation Places community entrepreneurship development project.  She is an advisor for HLK Pharmaceuticals, and she is a member of the boards of Bioxiness, Lamdavision, and Carogen. 

 Featured Speakers:

Mostafa Analoui, Ph.D., Executive Director, UConn Venture Development

"Biotech IPOs: Reading The Tea Leaves"

Mostafa Analoui, Ph.D., is Executive Director of UCONN Ventures. Previously, he was Head of Healthcare and Life Sciences at Livingston Securities (New York, NY) with investment focus in private and public companies in biotech, medtech and healthcare services. Prior to that he was the Senior Director at Pfizer Global Research and Development. Dr. Analoui is actively involved in investment, management and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging, and global strategies.

While at Pfizer, he was the Site Head for Global Clinical Technology in Groton and New London, a division focusing on emerging technologies for development and validation of biomarkers and diagnostics for drug development. Prior to joining Pfizer, Dr. Analoui was the Director of Oral and Maxillofacial Imaging Research, Associate Professor of Radiology at Indiana University, and Associate Professor of Biomedical Engineering and Electrical & Comp Engineering at Purdue University. He was also President and CEO of Therametric Technology Inc. He has received his Ph.D. from Purdue University, followed by Post-Doctoral Fellowship at IBM TJ Watson Research Center in NY.

Patrick Plues, Vice President, State Government Affairs, BIO

"Legislative Matters Arising Concerning the US-wide Bioscience Ecosystem"

Patrick Plues is a seasoned government affair and alliance development professional with twenty years experience in government and corporate public affairs. His career is focused in the biopharmaceutical industry where he has worked for the past fifteen years. 

Most recently, Patrick was Vice President for Government Affairs at The Conafay Group, a government and public affairs consulting firm specializing in the biopharmaceutical industry. Prior to The Conafay Group, he was Director of Federal Government Affairs at Cephalon, a global biopharmaceutical company where he was responsible for executing federal legislative/ policy strategies and representing company interests before the U.S. Congress and the Administration. He also led a team of alliance development and health policy and reimbursement professionals.

 
CURE is grateful to its many sponsors and members.  

Please plan to join us for an extravaganza of a community picnic on the grounds of The Commons, hosted by CURE, the Connecticut Technology Council and Crossroads Venture Group immediately following the panel presentation. 

There will be time for tours of technology laboratories and co-working space at CURE Innovations Commons

Catch up with colleagues, enjoy an Oyster bar, BBQ, some music, local wine and beer and celebrate the start of summer! Register here. 


Have questions about The CURE Annual Meeting? Contact CURE

Save This Event

Event Saved

When & Where


CURE Innovation Commons
93 Shennecossett Road
Groton, CT 06340

Tuesday, June 13, 2017 from 3:45 PM to 5:00 PM (EDT)


  Add to my calendar

Organizer

CURE

CURE serves as the bioscience cluster of Connecticut, a diverse network of small and large life and healthcare sciences companies, ranging in focus from biotherapeutics, to healthcare technology, to medical devices.  Universities, scientists, educators, mentors, students, entrepreneurs, business experts, service providers and investors join in to begin to complete the breadth of the network.  As participants in CURE, we cultivate entrepreneurship, build bioscience companies and collaborate to ensure a sustainable, high-value bioscience and healthcare community that improves our quality of life and keeps the Connecticut community strong.

  Contact the Organizer

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.